The results will support the company’s application for expanded labeling of its popular Farapulse pulsed field ablation ...

Boston Scientific Corp (BSX) stock saw a decline, ending the day at $100.31 which represents a decrease of $-0.60 or -0.59% from the prior close of $100.91. The stock opened at $100.91 and touched a ...

Boston Scientific outperforms competitors with strong growth in atrial fibrillation devices and recent acquisitions. Learn ...

Barclays raised the firm’s price target on Boston Scientific (BSX) to $111 from $86 and keeps an Overweight rating on the shares. The firm says ...

Results from the single-arm trial saw 63.5% of patients able to avoid the symptoms of Atrial fibrillation over the course of ...

Boston Scientific (NYSE: BSX) today reported data from separate studies backing its Farapulse and Watchman FLX systems.

Boston Scientific Corp (BSX) stock saw a modest uptick, ending the day at $98.66 which represents a slight increase of $0.49 or 0.50% from the prior close of $98.17. The stock opened at $97.93 and ...

Boston Scientific Corp. is paying $443 million upfront, plus up to $221 million in possible milestones, to buy the remainder ...

Morgan Stanley analyst Patrick Wood maintained a Buy rating on Boston Scientific (BSX – Research Report) today and set a price target of ...

Boston Scientific (BSX) announced on Wednesday the acquisition of the ~74% stake in Bolt Medical that the medical devices company does not already own.

We recently published a list of Billionaire Steve Cohen’s Top 15 Stock Picks. In this article, we are going to take a look at ...

Accurate Wealth Management LLC acquired a new stake in shares of Boston Scientific Co. (NYSE:BSX – Free Report) during the ...